Know Cancer

or
forgot password

Reducing Hair Loss With Volumetric Arc Therapy in Patients Treated With Whole Brain Radiotherapy: a Phase II Trial


Phase 2
18 Years
N/A
Not Enrolling
Both
Brain Metastases, Small Cell Lung Cancer

Thank you

Trial Information

Reducing Hair Loss With Volumetric Arc Therapy in Patients Treated With Whole Brain Radiotherapy: a Phase II Trial


Inclusion Criteria:



- Brain metastases

- Age ≥ 18 years.

- Signed informed consent

- Recursive Partitioning Analysis (RPA) class III patients

- Recursive Partitioning Analysis (RPA) class I-II patients and >3 brain metastases

- Patients with small cell lung cancer extended disease eligible for prophylactic
Whole-Brain Radiotherapy (WBRT).

Exclusion Criteria:

- Previous whole brain radiotherapy

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The European Organization for Research and Treatment of Cancer (EORTC)quality of life questionnaire (C15-PAL and BN20) measured at 1 month following treatment.

Outcome Description:

Quality of life questionnaires are used.

Outcome Time Frame:

At 1 month.

Safety Issue:

No

Authority:

Belgium: Ethics Committee

Study ID:

2011/504

NCT ID:

NCT01421316

Start Date:

January 2013

Completion Date:

October 2013

Related Keywords:

  • Brain Metastases
  • Small Cell Lung Cancer
  • Patients treated with whole brain radiotherapy in the setting of brain metastases
  • Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
  • Lung Neoplasms
  • Neoplasm Metastasis
  • Small Cell Lung Carcinoma
  • Brain Neoplasms

Name

Location